Pain and Emotional Well-Being Outcomes in Southwest Oncology Group–Directed Intergroup Trial S0205: A Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine As First-Line Therapy in Patients With Advanced Pancreas Cancer

PURPOSE: S0205 was a randomized clinical trial that compared the therapeutic impact of gemcitabine versus gemcitabine plus cetuximab. Study results for patient-reported health-related quality of life (HRQL) outcomes are reported. PATIENTS AND METHODS: Patients completed the Brief Pain Inventory and...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Moinpour, Carol M., Vaught, Nancy L., Goldman, Bryan, Redman, Mary W., Philip, Philip A., Millwood, Barbara, Lippman, Scott M., Seay, Thomas E., Flynn, Patrick J., O'Reilly, Eileen M., Rowland, Kendrith M., Wong, Ralph P., Benedetti, Jacqueline, Blanke, Charles D.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2010
Teme:
Original Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2917316/
https://ncbi.nlm.nih.gov/pubmed/20606094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.8285
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items